Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells - Sorbonne Université
Journal Articles Nucleic Acid Therapeutics Year : 2020

Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells

Nisha Verwey
  • Function : Author
Isabella Gazzoli
  • Function : Author
Sabine Krause
  • Function : Author
Friedrich-Baur-Institute, Department of Neurology
Kamel Mamchaoui
Centre de recherche en Myologie – U974 SU-INSERM
Vincent Mouly
Centre de recherche en Myologie – U974 SU-INSERM
Annemieke Aartsma-Rus
  • Function : Author
  • PersonId : 874763
Human Genetics

Domains

Life Sciences [q-bio] Biotechnology

Vincent Mouly  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-02905771

Submitted on : Thursday, July 23, 2020-4:54:39 PM

Last modification on : Friday, December 1, 2023-10:44:15 AM

Consult the full text

Dates and versions

hal-02905771 , version 1 (23-07-2020)

Identifiers

Cite

Nisha Verwey, Isabella Gazzoli, Sabine Krause, Kamel Mamchaoui, Vincent Mouly, et al.. Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells. Nucleic Acid Therapeutics, 2020, 30 (2), pp.71-79. ⟨10.1089/nat.2019.0788⟩. ⟨hal-02905771⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

U974 SORBONNE-UNIVERSITE SU-MEDECINE U974-MYOLINE
49 View
0 Download

Altmetric

Share

More